115 related articles for article (PubMed ID: 30842361)
1. Simple Risk Score to Predict Survival in Acute Decompensated Heart Failure - A
Nakada Y; Kawakami R; Matsushima S; Ide T; Kanaoka K; Ueda T; Ishihara S; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Okura H; Tsuchihashi-Makaya M; Tsutsui H; Saito Y
Circ J; 2019 Apr; 83(5):1019-1024. PubMed ID: 30842361
[TBL] [Abstract][Full Text] [Related]
2. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
4. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F
J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712
[TBL] [Abstract][Full Text] [Related]
5. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the A
Kyodo A; Nakada Y; Nogi M; Nogi K; Ishihara S; Ueda T; Tohyama T; Enzan N; Ide T; Matsushima S; Tsutsui H; Saito Y
J Am Heart Assoc; 2024 Feb; 13(4):e031104. PubMed ID: 38348810
[TBL] [Abstract][Full Text] [Related]
7. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function.
Stolfo D; Stenner E; Merlo M; Porto AG; Moras C; Barbati G; Aleksova A; Buiatti A; Sinagra G
Heart Lung Circ; 2017 Mar; 26(3):226-234. PubMed ID: 27523462
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
[TBL] [Abstract][Full Text] [Related]
10. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
[TBL] [Abstract][Full Text] [Related]
11. Predicting short-term mortality in advanced decompensated heart failure - role of the updated acute decompensated heart failure/N-terminal pro-B-type natriuretic Peptide risk score.
Scrutinio D; Ammirati E; Passantino A; Guida P; D'Angelo L; Oliva F; Ciccone MM; Iacoviello M; Dentamaro I; Santoro D; Lagioia R; Sarzi Braga S; Guzzetti D; Frigerio M
Circ J; 2015; 79(5):1076-83. PubMed ID: 25753469
[TBL] [Abstract][Full Text] [Related]
12. Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients.
Feola M; Testa M; Leto L; Cardone M; Sola M; Rosso GL
Medicine (Baltimore); 2016 Jun; 95(26):e4014. PubMed ID: 27368017
[TBL] [Abstract][Full Text] [Related]
13. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
[TBL] [Abstract][Full Text] [Related]
14. A simple risk score to predict in-hospital death of elderly patients with acute decompensated heart failure--hypoalbuminemia as an additional prognostic factor.
Kinugasa Y; Kato M; Sugihara S; Hirai M; Kotani K; Ishida K; Yanagihara K; Kato Y; Ogino K; Igawa O; Hisatome I; Shigemasa C
Circ J; 2009 Dec; 73(12):2276-81. PubMed ID: 19822976
[TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
[TBL] [Abstract][Full Text] [Related]
16. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study.
Lassus J; Gayat E; Mueller C; Peacock WF; Spinar J; Harjola VP; van Kimmenade R; Pathak A; Mueller T; Disomma S; Metra M; Pascual-Figal D; Laribi S; Logeart D; Nouira S; Sato N; Potocki M; Parenica J; Collet C; Cohen-Solal A; Januzzi JL; Mebazaa A;
Int J Cardiol; 2013 Oct; 168(3):2186-94. PubMed ID: 23538053
[TBL] [Abstract][Full Text] [Related]
17. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure.
Pascual-Figal DA; Bayes-Genis A; Asensio-Lopez MC; Hernández-Vicente A; Garrido-Bravo I; Pastor-Perez F; Díez J; Ibáñez B; Lax A
J Am Coll Cardiol; 2019 Mar; 73(9):1016-1025. PubMed ID: 30846095
[TBL] [Abstract][Full Text] [Related]
18. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
Eur J Heart Fail; 2015 Sep; 17(9):936-44. PubMed ID: 26222618
[TBL] [Abstract][Full Text] [Related]
19. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
[TBL] [Abstract][Full Text] [Related]
20. A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement.
Heidenreich PA; Tsai V; Curtis J; Wang Y; Turakhia MP; Masoudi FA; Varosy PD; Goldstein MK
Am Heart J; 2015 Aug; 170(2):281-289.e2. PubMed ID: 26299225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
